UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 13.

Jungraithmayr, W; De Meester, I; Matheeussen, V; Baerts, L; Arni, S; Weder, W (2012). CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. European Journal of Cardio-Thoracic Surgery, 41(5):1166-1173.

Wiedl, T; Collaud, S; Hillinger, S; Arni, S; Burgess, C; Kroll, W; Schraml, P; Soltermann, A; Moch, H; Weder, W (2012). KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma. Cancer Genomics & Proteomics, 9(1):51-54.

Meerwein, C; Korom, S; Arni, S; Inci, I; Weder, W; Jungraithmayr, W (2011). The effect of low-dose continuous erythropoietin receptor activator in an experimental model of acute Cyclosporine A induced renal injury. European Journal of Pharmacology, 671(1-3):113-119.

Inci, I; Arni, S; Acevedo, C; Jungraithmayr, W; Inci, D; Vogt, P; Weder, W (2011). Surfactant alterations following donation after cardiac death donor lungs. Transplant International, 24(1):78-84.

Wiedl, T; Arni, S; Roschitzki, B; Grossmann, J; Collaud, S; Soltermann, A; Hillinger, S; Aebersold, R; Weder, W (2011). Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma. Journal of Proteomics, 74(10):1884-1894.

Jungraithmayr, W; Vogt, P; Inci, I; Hillinger, S; Arni, S; Passlick, B; Korom, S; Weder, W (2010). A model of chronic lung allograft rejection in the rat. European Respiratory Journal, 35(6):1354-1363.

Collaud, S; Wiedl, T; Cattaneo, E; Soltermann, A; Hillinger, S; Weder, W; Arni, S (2010). Laser-capture microdissection impairs activity-based protein profiles for serine hydrolase in human lung adenocarcinoma. Journal of Biomolecular Techniques, 21(1):25-28.

Inci, I; Erne, B; Arni, S; Jungraithmayr, W; Inci, D; Hillinger, S; Vogt, P; Leskosek, B; Weder, W (2010). Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia. Journal of Heart and Lung Transplantation, 29(11):1293-1301.

Pedretti, M; Soltermann, A; Arni, S; Weder, W; Neri, D; Hillinger, S (2009). Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer. Lung Cancer, 64(1):28-33.

Ampollini, L; Soltermann, A; Felley-Bosco, E; Lardinois, D; Arni, S; Speck, R F; Weder, W; Opitz, I (2009). Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting. European Journal of Cardio-Thoracic Surgery, 35(3):457-462.

Zhai, W; Jungraithmayr, W; De Meester, I; Inci, I; Augustyns, K; Arni, S; Hillinger, S; Scharpé, S; Weder, W; Korom, S (2009). Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide. Transplantation, 87(8):1140-1146.

Inci, I; Ampollini, L; Arni, S; Jungraithmayr, W; Inci, D; Hillinger, S; Leskosek, B; Vogt, P; Weder, W (2008). Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. Journal of Heart and Lung Transplantation, 27(11):1229-1236.

Inci, I; Arni, S; Inci, D; Zhai, W; Hillinger, S; Leskosek, B; Vogt, P; Weder, W (2008). Impact of topical cooling solution and prediction of pulmonary graft viability from non-heart-beating donors. Journal of Heart and Lung Transplantation, 27(9):1016-1022.

This list was generated on Sat Jul 22 19:50:44 2017 CEST.